crc press - E-Lib FK UWKS

More documents

Recommendations

Info

Index 399 Diffraction, 168 Disulphide bond formation, 126 DnaJ proteins, 305 DnaK/Hsp70 proteins, 305 Doxorubicin blood–brain barrier delivery quantification, 273–274 penetratins and, 38–40, 46 Dye exclusion permeability assays, 248–249 E 18A peptide, 202 Electron paramagnetic resonance (EPR) spectroscopy, 177, 233 Electrostatic potential, 194–195 Electrostatics, interfacial, 229–231 Endoplasmic reticulum (ER), targeting to, 303–304 Enzymatic viability assays, 251 Enzyme activity assays, quantification by, 270 Epidermal growth factor receptor (EGFR), quantification of bioactivity, 272–274 Escherichia coli SecA protein of, 299 Tat proteins in, 302 Eubacterial signal peptides, specificity, 308–309 Eukaryotic secretion pathways, 303–305 cotranslational, 303–304 targeting to ER, 303–304 translocon complex, 304 post-translational, 304–305 chaperone proteins, 305 membrane proteins in addition to Sec, 304–305 Eukaryotic signal peptides, specificity, 309–310 Experimental methods antimicrobial peptides, 385–388 antimicrobial activity assays, 385–386 cell uptake assays, 386–388 cell permeabilization assays, 386–388 fluorescence microscopy and FACS, 386 MAPs, 87–90 cell culture, 87 confocal laser scanning microscopy, 88–90 HPLC analysis, 88 uptake experiments, 87–88 penetratins, 40–47 AntpHD and penetratin, 40–42 AntpHD and penetratin-coupled cargoes, 42–46 comments, 46–47 F transportans, 66–68 cargo–CPP conjugation systems, 66 conjugation to proteins, 66–67 disulfide heterodimers, 66 Factor-independent bacterial protein secretion pathways, 302–303 energetic aspects, 302–303 insertion of procoat proteins, 302 Fhh and 4.55 RNA-dependent bacterial protein secretion pathways, 300–301 Flow cytometry, quantification by, 268 Fluorescein radiolabeling, 281 Fluorescein retention assay, 251 Fluorescence-activated cell sorting (FACS), 268 in microbial membrane-permeating peptides, 386 Fluorescence resonance energy transfer (FRET), 239 Fluorescence studies, 231, 238–239 of membrane interactions, 169–177 electron paramagnetic resonance (EPR) spectroscopy, 177 multidisciplinary monolayer-based approach, 177–177 in microbial membrane-permeating peptides, 386 quantification by, 267–269 Fourier transform infrared spectroscopy, 167–168, 232 4.5S RNA, 300 FtsY-dependent bacterial protein secretion pathways, 301 G Galanin, 54 Galparan, 53–55, see also Transportan Giant unicellular vesicles (GUVs), 227–228 G-proteins transportan and, 66–67 transportans and, 58 Grp170–Orp150 protein, 305 GTPases, small, 370 H Haemophilus influenzae, 299 Herpes simplex virus VP22 protein, 116 HIV Tat peptide, 127, 131, see also Tat entries Homeoprotein-derived peptidic vectors, penetratins and, 24–26 antennapedia homeodomain, 24–25
400 Cell-Penetrating Peptides: Processes and Applications AntpHD mutant behavior, 25 penetratin-1 peptide, 25–26 HPLC, quantification by, 269–270 3 H radiolabeling, quantification by, 266–267 h-region peptides, 117–122, see also Membrane translocating (MTS) peptides HSP70 proteins, 305 Hydrophobicity atomic surface, 191–193 molecular hydrophobicity potential (MHP), 199–202, 206–208 Hydrophobic membrane translocating sequence peptides, 115–140, see also Membrane translocating sequence (MTS) peptides Hydrophobic peptides, structure prediction modeling, 202–204 I 125 I radiolabeling, quantification by, 266–267 Immunodetection, quantification by, 270 Incubation, of cells with CPPs, 279–280 Inhibition zone assay, 385 Integrin β 3 h-region, 122 Interfacial electrostatics, 229–231 Internalization, 287–293, see also Uptake; Uptake kinetics comparisons of CPPs and, 290–291 penetratins, 26–30 blood–brain barrier and, 39–40 direct perfusion in CNS, 39 immune system, 39 in vivo with penatratin-derived vectors, 39–40 peptide–lipid interactions, 28–29 peptides in blood vessels, 39 proposed models, 29–30 structural parameters and translocation, 26–28 vesicular, 177 via receptor, 177–179 Interphase region, 229–231 Interpretative criteria, 239–240 Ion pump uptake assays, 252 K KALA peptide, 356–357 Kaposi fibroblast growth factor (kFGF, FGF-4), 117–118, 120–122, 131 Kar2p (BiP) protein, 305 KFFKFFKFFK peptide, 357 Kinetics, uptake, 277–293, see also Uptake kinetics L Lactate dehydrogenase leakage assay, 249 Large unicellular vesicles (LUVs), 227 Leakage, as mechanism of antimicrobial action, 383–384 Leakage assays, 283 Lhs1p protein, 305 Lipid perturbation, 193–194 Lipid vesicles, determination of reduction rate constants, 271–272 Liposomes, 226–228 Loligomers, in nucleic acid delivery, 357–358 Lymphocytes, transduction into, 370 M Magainin, 236–238, 240 Magnetic cell labeling with Tat protein, 336–343 CLIO-Tat internalization into lymphocyte and CD34+ subsets, 336–337 internalization of paramagnetic chelates, 342–343 internalization of superparamagnetic nanoparticles, 336 label distribution in dividing cell populations, 337–338 results in vitro, 338–339 results in vivo, 339–340 toxicity/nontoxicity, 338 in vivo MR imaging of Tat-labeled cells, 340–342 Maltoporin, 204–206 MAP and MAP analogues, uptake kinetics, 290 MAPs, 71–92 experimental methods, 87–90 cell culture, 87 confocal laser scanning microscopy, 88–90 HPLC analysis, 88 uptake experiments, 87–88 introducing history, 72–73 toxicity, 252–253 uptake mammalian cell experiments, 84–87 mechanistic aspects, 73–76 structural requirements, 76–84 Mastoparan, 58, 59, see also Transportan Mastoparan X, 236–238, 240 Mechanisms and interactions, see also specific topics backbone and side chain variations, 141–160 biophysical studies, 223–244 membrane interactions, 163–183 quantification of CPPs and cargoes, 263–275 signal peptides, 295–324
Page 2 and 3:
CELL- PENETRATING PEPTIDES Processe
Page 4 and 5:
Pharmacology and Toxicology: Basic
Page 7 and 8:
Library of Congress Cataloging-in-P
Page 9 and 10:
to the handbook are prominent resea
Page 11 and 12:
REFERENCES 1. Green, M. and Loewens
Page 14 and 15:
Contributors Mats Andersson Microbi
Page 16 and 17:
Erin T. Pelkey Department of Chemis
Page 18 and 19:
Contents Section I Classes of Cell-
Page 20:
Chapter 16 Cell-Penetrating Peptide
Page 24 and 25:
1 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 26 and 27:
The Tat-Derived Cell-Penetrating Pe
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42:
Page 45 and 46:
24 Cell-Penetrating Peptides: Proce
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 74 and 75:
3 Transportans Margus Pooga, Mattia
Page 76 and 77:
Transportans 55 Indeed, galparan is
Page 78 and 79:
Transportans 57 especially the endo
Page 80 and 81:
Transportans 59 In the penetration
Page 82 and 83:
Transportans 61 A 21-mer antisense
Page 84 and 85:
Transportans 63 Commonly, the prote
Page 86 and 87:
Transportans 65 antibiotin antibodi
Page 88 and 89:
Transportans 67 For cross-linking o
Page 90 and 91:
Transportans 69 and still retain ef
Page 92 and 93:
4 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 94 and 95:
Model Amphipathic Peptides 73 its D
Page 96 and 97:
Model Amphipathic Peptides 75 pmol/
Page 98 and 99:
TABLE 4.1 Internalization of Peptid
Page 100 and 101:
TABLE 4.2 Internalization of Peptid
Page 102 and 103:
Model Amphipathic Peptides 81 relat
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Model Amphipathic Peptides 87 A cat
Page 110 and 111:
Model Amphipathic Peptides 89 At th
Page 112 and 113:
Model Amphipathic Peptides 91 16. H
Page 114 and 115:
5 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 116 and 117:
Signal Sequence-Based Cell-Penetrat
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134:
Page 137 and 138:
116 Cell-Penetrating Peptides: Proc
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 184 and 185:
8 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 186 and 187:
Interactions of Cell-Penetrating Pe
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
9 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 210 and 211:
Structure Prediction of CPPs and It
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
FIGURE 9.7 (Color Figure 9.7 follow
Page 230 and 231:
FIGURE 9.8 The center of the figure
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
10 CONTENTS 0-8493-1141-1/02/$0.00+
Page 246 and 247:
Biophysical Studies of Cell-Penetra
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
11 CONTENTS 0-8493-1141-1/02/$0.00+
Page 268 and 269:
Toxicity and Side Effects of Cell-P
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 298 and 299:
13 CONTENTS 0-8493-1141-1/02/$0.00+
Page 300 and 301:
Kinetics of Uptake of Cell-Penetrat
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 348 and 349:
15 CONTENTS 0-8493-1141-1/02/$0.00+
Page 350 and 351:
Cell-Penetrating Peptide Conjugatio
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
FIGURE 15.9 (Color Figure 15.9 foll
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
16 CONTENTS 0-8493-1141-1/02/$0.00+
Page 370 and 371: Cell-Penetrating Peptides as Vector
Page 374 and 375: TABLE 16.1 Examples of Transport of
Page 380 and 381: CPP 2 Cargo or mRNA CAP Antisense A
Page 384: Cell-Penetrating Peptides as Vector
Page 387 and 388: 366 Cell-Penetrating Peptides: Proc
Page 398 and 399: 18 CONTENTS 0-8493-1141-1/02/$0.00+
Page 400 and 401: Microbial Membrane-Permeating Pepti
Page 418 and 419: Index A Abaecin, 129 Abz radiolabel
Page 422 and 423: Index 401 structure prediction, 187
Page 424 and 425: Index 403 pRB proteins, Tat-E1A bin
Page 426 and 427: Index 405 lipid perturbation (secon
show all

crc press - E-Lib FK UWKS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?